Lyell Immunopharma Raises Approximately $80 Million via Private Placement
Lyell Immunopharma (LYEL) has entered into a securities purchase agreement to raise approximately $80 million through a private placement of common stock. The transaction involves the issuance of 7.43 million shares at a price of $10.77 per share. The capital infusion is expected to close around November 4, 2026. Following the announcement, Lyell's shares saw a significant market reaction, rising by 35% as investors reacted to the funding news.